[Danruo International News Update] Danruo International Joins Forces with Longyan Hongfangzi Maternity Hospital to Embark on a New Journey in Reproductive Medicine

On October 20, 2024, a landmark medical event commenced in the conference room—brimming with distinguished guests and vibrant energy. Danruo International Reproductive Hospital and Longyan Hongfangzi Maternity Hospital officially signed a Medical Consortium Cooperation Agreement, ushering in a new chapter of collaborative alliance, mutual benefit, and shared development. This partnership is poised to trigger transformative change across the fertility medicine industry.

On October 20, 2024, a landmark medical event commenced in the conference room—brimming with distinguished guests and vibrant energy. Danruo International Reproductive Hospital and Longyan Hongfangzi Maternity Hospital officially signed a Medical Consortium Cooperation Agreement, ushering in a new chapter of collaborative alliance, mutual benefit, and shared development. This partnership is poised to trigger transformative change across the fertility medicine industry.

Technical exchange and collaboration between the two hospitals have now entered an entirely new phase. Longyan Hongfangzi Maternity Hospital has cultivated deep expertise and accumulated rich, invaluable experience in obstetrics and gynecology over many years; meanwhile, Danruo International Reproductive Hospital excels in IVF technology, international-standard healthcare services, and patient-centered experience. Through regularly scheduled technical seminars and hands-on training sessions, clinical staff gain in-depth exposure to each other’s advanced techniques and service philosophies—enabling knowledge sharing and continuous professional advancement.

To enhance public awareness of infertility, both hospitals jointly conduct online and offline outreach initiatives. Experts deliver accessible, easy-to-understand explanations of fundamental infertility concepts, patiently address patients’ questions, and provide empathetic psychological support—ensuring patients feel warmth and care.

At this signing ceremony, Danruo International Reproductive Hospital fielded a distinguished delegation: Dr. Wenlin Peng, Hospital Director; Dr. Lili Huang, Ph.D. in Reproductive Medicine from Sun Yat-sen University and Senior Reproductive Medicine Specialist; Dr. Jianming Li, Director of the U.S.-based High-Precision Complex Clinical Laboratory and Accredited Inspector for the College of American Pathologists (CAP); and Dr. Bingbing Deng, formerly of the Reproductive Medicine Department at Xiamen Maternal and Child Health Care Hospital. They engaged in in-depth academic exchanges with Dr. Jin Wang, Director of Longyan Hongfangzi Maternity Hospital.

At the academic exchange, Dr. Wenlin Peng proudly introduced that all physicians and embryologists at Danruo International Reproductive Hospital have undergone rigorous training at world-class reproductive institutions abroad, accumulating extensive clinical experience. Patient welfare remains their unwavering priority—they race against time, never missing a single optimal treatment window. To safeguard oocyte quality, medical staff routinely sacrifice personal rest, operating round-the-clock for patients who have experienced repeated IVF implantation failures. One documented case illustrates this commitment: oocyte retrieval performed at 10:00 p.m., followed by fertilization and embryo culture commencing at 2:00 a.m. the next day. Such 24/7 operational capacity is exceptionally rare globally—powerfully reflecting the hospital’s profound sense of responsibility toward patients.

Dr. Wenlin Peng also offered high praise for Longyan Hongfangzi Maternity Hospital: “The expert team, infrastructure, technical protocols, and service model at Longyan Hongfangzi Maternity Hospital fully meet Danruo Reproductive Hospital’s stringent partnership criteria. Their exceptional efficiency enables completion of diagnostic testing and reporting within just two hours—securing precious time for high-quality oocyte retrieval and embryo transfer. The hospital demonstrates profound expertise in pregnancy maintenance, maintains ample pharmaceutical inventory, ensures safe and painless delivery, and delivers robust postpartum rehabilitation support. This strategic collaboration will undoubtedly provide highly effective assistance to individuals and couples seeking fertility solutions—and help them realize their dream of parenthood!”

In his speech, Dr. Jin Wang, Director of Longyan Hongfangzi Maternity Hospital, noted that municipal departments in Longyan have actively responded to the requirements outlined in the Third Plenary Session of the 20th Central Committee of the Communist Party of China—specifically, strengthening population development support and service mechanisms. With people at the center, these efforts continuously optimize the business environment and empower healthcare institutions to innovate in population-related services. Longyan Hongfangzi Maternity Hospital has achieved remarkable outcomes in infertility diagnosis and treatment, while Danruo International Reproductive Hospital introduces cutting-edge U.S. technologies and delivers personalized assisted reproduction services. This collaboration aims to enhance service accessibility and patient satisfaction—ultimately benefiting local communities.

According to official reports, the national infertility rate has risen to 15%, and demand for IVF services in Fujian Province is surging. Longyan Hongfangzi Hospital has long been dedicated to reproductive health—making significant contributions behind the scenes. Now, through its partnership with Danruo International Reproductive Hospital, patients will receive integrated, one-stop care—eliminating the need to travel extensively and enabling seamless access to high-quality medical resources.

The establishment of this Medical Consortium between Longyan Hongfangzi Maternity Hospital and Danruo International Reproductive Hospital not only supports national population development goals but also improves healthcare accessibility, alleviates patient burdens, and brings renewed hope to families affected by infertility.

Following the signing ceremony, a dynamic academic symposium on reproductive health and infertility management took place. Engaging presentations by Dr. Jianming Li and Dr. Lili Huang immersed attendees in a high-caliber academic experience. Dr. Lili Huang further demonstrated exceptional dedication—patiently answering questions and generously sharing insights and practical experience without reservation.

Guided by the principle of prioritizing patient well-being, Danruo International Reproductive Hospital and Longyan Hongfangzi Maternity Hospital will join forces as complementary leaders—collaboratively launching a new era in reproductive health and infertility treatment. Leveraging their respective strengths in talent development, technical capability, equipment sophistication, and discipline building, the two hospitals will achieve resource sharing and synergistic advantage—jointly advancing reproductive wellness services. They are committed to designing specialized, individualized IVF protocols for families pursuing assisted reproduction, ensuring optimal birth outcomes and fulfilling every family’s aspiration for parenthood—spreading joy and smiles to more households.

This article is a public-information summary published by WFA. It is intended for industry, media and the general public, and does not constitute medical or investment advice.